Área Sanitaria de Ourense, Verín e O Barco de Valdeorras
Área sanitaria
Hospital do Meixoeiro
Vigo, EspañaPublicacións en colaboración con investigadores/as de Hospital do Meixoeiro (45)
2024
2023
-
Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 58
-
The activity of psoriatic arthritis with axial involvement correlates with the PsAID12
Reumatologia Clinica
2022
-
Parkinson's disease and diabetes mellitus: Common mechanisms and treatment repurposing
Neural Regeneration Research, Vol. 17, Núm. 8, pp. 1652-1658
2020
-
Hydroxychloroquine is associated with a lower risk of polyautoimmunity: Data from the RELESSER Registry
Rheumatology (United Kingdom), Vol. 59, Núm. 8, pp. 2043-2051
2019
-
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: Prevalence and clinical relevance in a large international, multi-ethnic cohort of patients
Clinical and Experimental Rheumatology, Vol. 37, pp. S97-S106
-
The Big Data Sjögren consortium: A project for a new data science era
Clinical and Experimental Rheumatology, Vol. 37, pp. S19-S23
2018
-
How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: Analysis of 10,500 patients (Sjögren Big Data Project)
Clinical and Experimental Rheumatology, Vol. 36, pp. S102-S111
2016
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
-
Systemic activity and mortality in primary Sjögren syndrome: Predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients
Annals of the Rheumatic Diseases, Vol. 75, Núm. 2, pp. 348-355
-
The IASLC lung cancer staging project: Proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for lung cancer
Journal of Thoracic Oncology, Vol. 11, Núm. 1, pp. 39-51
2014
-
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)
BMC Cancer, Vol. 14, Núm. 1
-
Systemic involvement in primary Sjögren's syndrome evaluated by the EULAR-SS disease activity index: Analysis of 921 spanish patients (GEAS-SS registry)
Rheumatology (United Kingdom), Vol. 53, Núm. 2, pp. 321-331
-
Tumor, node and metastasis classification of lung cancer - M1a versus M1b - Analysis of M descriptors and other prognostic factors
Lung Cancer, Vol. 84, Núm. 2, pp. 182-189
2013
-
Genetic susceptibility variants associated with colorectal cancer prognosis
Carcinogenesis, Vol. 34, Núm. 10, pp. 2286-2291
-
Miopatía por deficiencia de mioadenilato desaminasa desencadenada por el tratamiento con atorvastatina
Medicina Clinica
2012
-
COGENT (COlorectal cancer GENeTics) revisited
Mutagenesis, Vol. 27, Núm. 2, pp. 143-151
2011
-
5-fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer
Gastroenterology, Vol. 140, Núm. 4, pp. 1174-1181
-
Case-control study for colorectal cancer genetic susceptibility in EPICOLON: Previously identified variants and mucins
BMC Cancer, Vol. 11
-
Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus
Chest, Vol. 139, Núm. 3, pp. 555-562